Publicações

Retraction Note: Trib2 Confers Resistance to Anti-Cancer Therapy by Activating the Serine/Threonine Protein Kinase Akt (Nature Communications, (2017), 8, 1, (14687), 10.1038/Ncomms14687)

AuthID
P-00Y-SG4

Author(s)

Hill, R

Madureira, A

Ferreira, B

Baptista, I

Machado, S

Colaҫo, L

dos Santos, M

Liu, N

Dopazo, A

Ugurel, S

Adrienn, A

Kiss Toth, E

Isbilen, M

Gure, O

Link, W

Tipo de Documento

Correction

Year published

2023

Publicado

in Nature Communications, ISSN: 2041-1723

Volume: 14, Número: 1

Indexing

Scopus^®

Crossref^®

Pubmed^®

Google Scholar^®

Metadata
Fontes

Publication Identifiers

DOI: 10.1038/s41467-023-40050-1

Pubmed: 37468494

SCOPUS: 2-s2.0-85165418812

Source Identifiers

ISSN: 2041-1723

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

Retraction Note: Trib2 Confers Resistance to Anti-Cancer Therapy by Activating the Serine/Threonine Protein Kinase Akt (Nature Communications, (2017), 8, 1, (14687), 10.1038/Ncomms14687)

Links Úteis

Ajuda

Autenticação Federada (Clique na imagem)

Retraction Note: Trib2 Confers Resistance to Anti-Cancer Therapy by Activating the Serine/Threonine Protein Kinase Akt (Nature Communications, (2017), 8, 1, (14687), 10.1038/Ncomms14687)

Links Úteis

Ajuda